

The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients.
Idorsia’s success depends on its people.
Idorsia's development compounds target a number of different diseases.
04 Feb 2021 | |
02 Feb 2021 | |
11 Jan 2021 |
Event | When |
First Quarter 2021 Financial Results reporting* | April 22, 2021 |
Annual General Meeting of Shareholders | May 12, 2021 |
Half-Year 2021 Financial Results reporting* | July 27, 2021 |
Nine-months 2021 Financial Results reporting* |
October 26, 2021
|
*We will be in a silent period for 10 days ahead of the financial reporting.